| answer text |
<p>The UK National Screening Committee makes recommendations on whole population screening
programmes. It is for the National Institute for Health and Care Excellence or its
accredited guideline producing bodies to recommend care and testing of people at high
risk.</p><p> </p><p> </p><p> </p><p>NHS England has commissioning arrangements in
place for carrier testing for Tay Sachs disease for at risk populations. Genetic testing
will be undertaken where there is a known family history, which indicates a risk of
the specific condition or in response to the individual’s clinical symptoms. In the
absence of a family history or clinical symptoms it is the responsibility of clinical
commissioning groups based on their local needs as to whether they fund referrals
to clinical genetics for carrier screening for Tay Sachs disease.</p><p> </p><p> </p><p>
</p><p>Genomics offers a great opportunity to improve our insight into genetic diseases.
It is for this reason that the Government launched a world-leading project to sequence
100,000 genomes from National Health Service patients and established Genomics England,
a subsidiary of the Department, to deliver the project.</p><p> </p>
|
|
